Le Lézard
Classified in: Science and technology
Subject: PDT

Nightstick Introduces Upgraded Multi-Purpose Flashlights


WYLIE, Texas, May 23, 2018 /PRNewswire-PRWeb/ -- Check out the VIDEO!

Nightstick's innovative Dual-Lighttm Technology proves that two is always better than one, and the new Nightstick NSP-2422 X-Series Multi-Purpose Flashlights demonstrate how a unique design can make all the difference. The upgraded NSP-2424GMX (green housing) and model NSP-2424YMX (yellow housing) X-Series Dual-Light Flashlights feature a significant lumen increase over previous models while keeping two independent LEDs and two integrated magnets for complete hands-free use.
With the focused and crisp LED flashlight beam (now boasting 300 lumens), you'll get superb distance illumination. The downward unfocused floodlight (now 200 lumens) is ideal for both proximity lighting on close-up tasks while also safeguarding against slips, trips and falls that went previously unseen. Activating both top-mounted independent switches in dual-light mode (now 350 lumens) maximizes your visibility and delivers convenience never seen before.

Even though the lumen output is the primary focus of the 2424 series enhancement, the optimal placement of the integrated magnets stays the same with an impressive 6 hours of flashlight or floodlight run-time. One magnet is placed on the base of the housing, and the other is found on the robust built-in pocket/belt clip, providing unlimited user amenities.

"Once you attach the 2424 to a metal surface, it's easy to position the enhanced flashlight or floodlight into an ideal position based on your need for light," says Russell Hoppe, Marketing Manager for Nightstick. "When you consider the increased lumens in both the flashlight and floodlight, add the flexibility of the magnets in a waterproof, impact resistant design...you're getting a ton of value in one versatile product. Your new go-to flashlight just got an upgrade."

The NSP-2424GMX and 2424YMX feature an PC/ABS housing that is IP-X7 rated waterproof, as well as chemical and impact resistant. Included are 3 AA alkaline batteries and a removeable lanyard, all backed by a limited 1-year warranty. To learn more, please visit http://www.nightstick.com.

About NIGHTSTICK®
Designed and manufactured by Bayco Products, Inc., Nightstick is a global brand of professional lighting products, including flashlights, headlamps and Intrinsically Safe lighting solutions that continue to exceed industry standards in performance, quality, user-safety, and value. Nightstick's vast line-up of LED lighting products deliver optimal performance with real-world applications in mind. With an unwavering commitment to product quality and exceptional customer service, Nightstick ? Life Depends on LightTM.

To find a global retailer near you, visit: http://www.nightstick.com/wtb-ns

Find us on social media:
Facebook
Twitter
Instagram
LinkedIn
Pinterest
Google+
YouTube

 

SOURCE Nightstick


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: